 The current protocol will collect additional assessments of neurocognition executive function, processing speed, and memory, endothelial function brachial artery flow-mediated dilation, and cerebrovascular reserve a measure of prefrontal cortex tissue oxygenation in 120 participants at baseline, following completion of the 4-month intervention, and again after one year, in order to examine neurocognitive improvements and their potential mediators. 